MedPath

HEMATOGEN FORTE

Hematogen Forte

Approved
Approval ID

dfc69d93-0796-4ae5-888e-0f7d81f19b2e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 28, 2023

Manufacturers
FDA

Nnodum Pharmaceuticals

DUNS: 960457273

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN

PRODUCT DETAILS

NDC Product Code63044-633
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationORAL
Effective DateDecember 23, 2021
Generic NameFERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN

INGREDIENTS (9)

FERROUS FUMARATEActive
Quantity: 151 mg in 1 1
Code: R5L488RY0Q
Classification: ACTIM
SOYBEAN OILInactive
Code: 241ATL177A
Classification: IACT
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYDROGENATED SOYBEAN OILInactive
Code: A2M91M918C
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
ASCORBIC ACIDActive
Quantity: 1 mg in 1 1
Code: PQ6CK8PD0R
Classification: ACTIB
FOLIC ACIDActive
Quantity: 10 mg in 1 1
Code: 935E97BOY8
Classification: ACTIB
CYANOCOBALAMINActive
Quantity: 10 mg in 1 1
Code: P6YC3EG204
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HEMATOGEN FORTE - FDA Drug Approval Details